Advertisement Advertisement Advertisement Advertisement


February 8, 2017
  • When Is Subclinical Hypothyroidism Treatment Optimal in Pregnant Women?

    A new study has determined when treatment is most beneficial for pregnant women with subclinical hypothyroidism, allowing pharmacists to reassure expectant mothers weighing the risks and benefits of levothyroxine therapy. Find out the dilemma and how the researchers resolved it.

  • New Population Study Debunks Link Between ADT, Alzheimer’s Disease

    A study last fall caused concern among prostate cancer patients and physicians treating them by linking androgen deprivation therapy and increased risk of dementia. A new large-scale population study was unable to replicate those results, however, and suggests the previous research was skewed by methodological issues. Here are the details.

  • Verapamil Shows Promise for Treating Severe
    Chronic Rhinosinusitis
    A blood pressure medication around for more than half a century is being touted as a possible wonder drug for a hard-to-treat condition—chronic rhinosinusitis with nasal polyps. Find out how verapamil alleviated the condition in a recent trial.
  • New Standards Should Improve Accuracy of Hypogonadism Diagnoses

    Pharmacists have been deluged with prescriptions for low “T” therapy over the last decade or so, and questions have been raised about what percentage of patients might not actually have hypogonadism. New research should clear up some of the confusion by defining reference ranges of testosterone and standardized hormone assays. Here is more information.

Connect With U.S. Pharmacist
USP Google AppUSP Itunes App